Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 2
2009 4
2010 4
2011 4
2012 3
2013 2
2014 3
2015 2
2016 2
2019 1
2020 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
1-(6-Fluoro-1,3-benzothia-zol-2-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde.
Fun HK, Ooi CW, Munirajasekhar D, Himaja M, Sarojini BK. Fun HK, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3458-9. doi: 10.1107/S1600536811049634. Epub 2011 Nov 30. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 22199936 Free PMC article.
Ethyl 1-(4-chloro-benz-yl)-3-phenyl-1H-pyrazole-5-carboxyl-ate.
Hao BQ, Xu WR, Meng FC, Duan GY. Hao BQ, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):o877. doi: 10.1107/S1600536812007428. Epub 2012 Feb 29. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22412729 Free PMC article.
1-(4-tert-Butyl-benz-yl)-3-phenyl-1H-pyrazole-5-carboxylic acid.
Tang Z, Ding XL, Xie YS, Zhao BX. Tang Z, et al. Acta Crystallogr Sect E Struct Rep Online. 2009 May 14;65(Pt 6):o1273. doi: 10.1107/S1600536809017000. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21583135 Free PMC article.
Novel thiol-based histone deacetylase inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif: Design, synthesis and SAR study.
Wen J, Niu Q, Liu J, Bao Y, Yang J, Luan S, Fan Y, Liu D, Zhao L. Wen J, et al. Bioorg Med Chem Lett. 2016 Jan 15;26(2):375-379. doi: 10.1016/j.bmcl.2015.12.007. Epub 2015 Dec 7. Bioorg Med Chem Lett. 2016. PMID: 26706171
A series of novel thiol-based histone deacetylase (HDAC) inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide scaffold as surface recognition motif was designed, synthesized, and evaluated for their HDAC inhibition activity. ...In addition, Structure- …
A series of novel thiol-based histone deacetylase (HDAC) inhibitors bearing 3-phenyl-1H-pyrazole-5-carboxamide s …
Synthesis and evaluation of the antifungal activity of 5-hydroxy-3-phenyl-1H-pyrazole-1-carbothioamide for use in the oral environment.
Amin Zadeh H, Zomorodkia AA, Hadi S, Mohammad Zadeh I, Sabetghadam SAA, Hadi V. Amin Zadeh H, et al. J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):211-215. doi: 10.1016/j.jobcr.2024.01.008. Epub 2024 Mar 1. J Oral Biol Craniofac Res. 2024. PMID: 38445048 Free PMC article.
This study aimed to synthesize a new azole compound and investigate its antifungal activity. METHODS: In this experimental study, 5-hydroxy-3-phenyl-1H-pyrazole-1-carbothioamide was synthesized by the reaction between thiosemecarbazide and ethylbezoyla …
This study aimed to synthesize a new azole compound and investigate its antifungal activity. METHODS: In this experimental study, 5-hydroxy- …
Calix[4]arene-pyrazole conjugates as potential cancer therapeutics.
Muravev AA, Voloshina AD, Sapunova AS, Gabdrakhmanova FB, Lenina OA, Petrov KA, Shityakov S, Skorb EV, Solovieva SE, Antipin IS. Muravev AA, et al. Bioorg Chem. 2023 Oct;139:106742. doi: 10.1016/j.bioorg.2023.106742. Epub 2023 Jul 17. Bioorg Chem. 2023. PMID: 37480816
Tumor selectivity is yet a challenge in chemotherapy-based cancer treatment. A series of calixarenes derivatized at the lower rim with 3-phenyl-1H-pyrazole units with variable upper-rim substituent and conformations of macrocyclic core, alkyl chain len …
Tumor selectivity is yet a challenge in chemotherapy-based cancer treatment. A series of calixarenes derivatized at the lower rim with 3
A simple hydrogen-bonded chain in (3Z)-3-{1-[(5-phenyl-1H-pyrazol-3-yl)amino]ethylidene}-4,5-dihydrofuran-2(3H)-one, and a hydrogen-bonded ribbon of centrosymmetric rings in the self-assembled adduct (3Z)-3-{1-[(5-methyl-1H-pyrazol-3-yl)amino]ethylidene}-4,5-dihydrofuran-2(3H)-one-6-(2-hydroxyethyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7(4H)-one (1/1).
Quiroga J, Portilla J, Cobo J, Glidewell C. Quiroga J, et al. Acta Crystallogr C. 2010 Jan;66(Pt 1):o25-8. doi: 10.1107/S0108270109052846. Epub 2009 Dec 12. Acta Crystallogr C. 2010. PMID: 20048419
(3Z)-3-{1-[(5-Phenyl-1H-pyrazol-3-yl)amino]ethylidene}-4,5-dihydrofuran-2(3H)-one, C(15)H(15)N(3)O(2), (I), and the stoichiometric adduct (3Z)-3-{1-[(5-methyl-1H-pyrazol-3-yl)amino]ethylidene}-4,5-dihydrofuran-2(3H)-one-6-(2-hydroxyethyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7(4H …
(3Z)-3-{1-[(5-Phenyl-1H-pyrazol-3-yl)amino]ethylidene}-4,5-dihydrofuran-2(3H)-one, C(15)H(15)N(3)O(2), (I), and the stoichiometric adduct (3 …
30 results